Chiara Moltrasio

Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*

Angelo Valerio Marzano, Giovanni Genovese, Giovanni Casazza et al. · British Journal of Dermatology · 2020 · 172 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study

Kelsey R. van Straalen, Thrasyvoulos Tzellos, Phillipe Guillem et al. · Journal of the American Academy of Dermatology · 2021 · 93 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

The clinical spectrum of COVID-19–associated cutaneous manifestations: An Italian multicenter study of 200 adult patients

Angelo Valerio Marzano, Giovanni Genovese, Chiara Moltrasio et al. · Journal of the American Academy of Dermatology · 2021 · 81 citations · Full text

Medicine, Dermatology, Infectious Diseases +16

International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut‐off values for defining mild, moderate and severe types of bullous pemphigoid*

W. Masmoudi, Marc Le Vaillant, Snejina Vassileva et al. · British Journal of Dermatology · 2020 · 63 citations

Medicine, Dermatology, Pathology +15

PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa

Simone Garcovich, Giovanni Genovese, Chiara Moltrasio et al. · Clinics in Dermatology · 2020 · 62 citations

Medicine, Dermatology, Pathology +7